Paradoxically, although omentin-1 is mainly secreted by the visceral adipose tissue, circulating levels of omentin-1 are downregulated in obesity-associated metabolic disorders, i.e., insulin resistance and T2DM, following the pattern of adiponectin [14,20]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.